Coherus Biosciences (CHRS) P/E (2014 - 2026)
Coherus Biosciences (CHRS) P/E from Dec 31, 2014 to Jul 21, 2026. The TTM Coherus Biosciences (CHRS) P/E is 0.87. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Coherus Biosciences (CHRS)
| Year | P/E | Change |
|---|---|---|
| 2026 | 0.87 | -11.09% |
| 2025 | 0.97 | -81.47% |
| 2024 | 5.26 | -495.46% |
| 2023 | -1.33 | -39.63% |
| 2022 | -2.20 | -46.82% |
| 2021 | -4.14 | -144.26% |
| 2020 | 9.36 | -107.46% |
| 2019 | -125.36 | +882.16% |
| 2018 | -12.76 | +270.10% |
| 2017 | -3.45 | -55.83% |
| 2016 | -7.81 | +104.48% |
| 2015 | -3.82 | -79.51% |
| 2014 | -18.63 | N/A |
Comparison Coherus Biosciences (CHRS) P/E with competitors
Coherus Biosciences (CHRS) P/E is 0.87.